RAC 2.20% $1.78 race oncology ltd

Interesting article on the evolving landscape of cancer drug...

  1. 96 Posts.
    lightbulb Created with Sketch. 62
    Interesting article on the evolving landscape of cancer drug trials. I think the team at Race are well across this.

    https://www.nature.com/articles/d41586-024-01430-9?utm_medium=paid_social&utm_source=facebook&utm_content=null&utm_term=null&utm_campaign=MLSR_OUTLK_AWA1_GL_PCFU_CFULF_NOVCAN-324&fbclid=IwAR33PBYhgtpj9rvOUDZbsjYQrfGQQfv_uP_g5t-gZqpM4tynbl9_kra8MF4_aem_AQjnV5EhC7mVBv_ROslP6lQgB_zHTFMwekc8HnmyiuqrBFM6nE5NQ9EH00Q8FKhcWtCbB_DmggYjtLcs33Obekuu
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.